FDA New, GMP Do
Clinical Phase II, III Intermediates
GMP Custom synthesis, Full Document
R&D Center: 8000 sq, More than 100 hoods
Pilot Plant: 20000sq, 40 reactors from 5-200L
Manufacturing Site: 800000sq, 40 reactors from 100-5000L
Web: www.eosmedchem.com
This is my R&D youtube: https://youtu.be/r5cJdXKNXHk
| LY-231617, 141545-89-3 ;93811-58-6 (free), LY-231617 Intermediate 1620-98-0, stock 553.7g, white powder, assay by HPLC 98.2%, HNMR, LCMS we supply. |
| LY-231617, 141545-89-3 ;93811-58-6 (free), LY-231617 Intermediate 93811-58-6, stock 198.3g, white powder, assay by HPLC 98.2%, HNMR, LCMS we supply. |
